Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report published on Tuesday morning. The brokerage issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Trading Up 26.4 %

Shares of MLSS opened at $1.00 on Tuesday. The stock has a market capitalization of $77.89 million, a price-to-earnings ratio of -14.29 and a beta of 1.08. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.10. The firm has a fifty day simple moving average of $0.83 and a 200 day simple moving average of $0.84.

Insider Buying and Selling

In other news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now directly owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Over the last three months, insiders have sold 109,193 shares of company stock worth $101,634. Insiders own 24.75% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific during the third quarter worth approximately $48,000. World Investment Advisors LLC bought a new position in shares of Milestone Scientific during the third quarter worth approximately $91,000. Finally, Geode Capital Management LLC lifted its holdings in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.